Sun Pharma reports Q2FY22 results
Q2 Gross Sales at Rs. 95,567 million up 13% YoY Q2 Net Profit at Rs. 20,470 million up 29% v/s ...
Read moreDetails
Tag: Sun Pharma
“Despite challenging conditions, we have done well and have not lost market share for any of our key specialty products in the US.” Says Dilip Shanghvi, Managing Director, Sun Pharmaceutical Industries Limited
Gross Sales at Rs.7,467crores Adjusted Net Profit at Rs. 1,146crores Mumbai, July31,2020: Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, ...
Read moreDetails
